News - The Clinic of Change

News

"SAPO: What happens to our brain during a trip? The answer from neuroscientist David Nutt

What goes on in the brain during a trip remains one of the great unanswered questions of neuroscience, even though we know a lot more than we did 15 years ago. British neuropsychopharmacologist David Nutt sheds light on this question in the excerpt we publish from his book "Psychedelics".

"Financial Times": Could psychedelics be the solution to depression at work?

This drug is being provided to workers through company health insurance as the popularity of psychedelic-assisted psychotherapy grows.

"Vice": I did psychotherapy with psychedelics and that's how it went.

"One thing that was very important to me was feeling more present in my body and in my life throughout the process. I'd never felt so clear-headed and, like most people, I'd never spent four weeks so intensely dedicated to understanding and improving myself."

"New Scientist: The unlikely transformation of a psychedelic drug into a mental health treatment.

Driven by impressive clinical trials, some companies are offering this type of therapy as a health benefit for their employees - but what are the risks of this growing popularity?

"The Standard": Denying access to psychedelics is like denying access to the Covid-19 vaccine.

Neuropsychopharmacologist and former government medicines official Professor David Nutt has become one of the leading scientists defending the right to psychedelic medicine for mental health. In this interview, he explains that the time to legalize is now.

"The Economist": A new therapy for traumatized Ukrainian soldiers: ketamine.

This drug has been authorized in Ukraine as a treatment for mental illness since 2017. But now soldiers with war trauma are being treated with ketamine to "relieve emotional pressure".

"Público": These are illicit drugs that can have therapeutic benefits

Ketamine, MDMA, psilocybin and cannabis have in common the fact that they are illicit drugs and have therapeutic properties. As the potential of these substances is the subject of various experiments, the results of which have been promising, SICAD has organized a thematic dossier.

"Time": The evolutionary origins of psychedelics

Humans rely on a strange set of natural chemicals. The big question is why plants, mushrooms and microbes, and even some animals, produce chemicals with life-saving properties. My job as an evolutionary biologist studying the ancient battle between plants and herbivores is precisely to answer this question. In doing so, we can gather essential information about the potential of the chemicals that have been forged by evolution.